Eastern Drugs And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.75 M
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
About Eastern Drugs And Research Centre
Eastern Drugs And Research Centre Private Limited (EDARCPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 November 2005 and has a history of 19 years and two months. Its registered office is in Sakchi,Jamshedpur-831001, Jharkhand.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.75 M, as per Ministry of Corporate Affairs (MCA) records.
Bajranglal Choudhary, Shree Choudhary, and Shourya Choudhary serve as directors at the Company.
Company Details
- Location Sakchi,Jamshedpur-831001, Jharkhand
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230JH2005PTC011771
- Company No.
011771
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Nov 2005
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Who are the key members and board of directors at Eastern Drugs And Research Centre?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bajranglal Choudhary  | Director | 29-Nov-2005 | Current |
| Shree Choudhary | Director | 23-Jul-2016 | Current |
| Shourya Choudhary | Director | 01-Apr-2024 | Current |
Financial Performance of Eastern Drugs And Research Centre.
Eastern Drugs And Research Centre Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Eastern Drugs And Research Centre?
In 2017, Eastern Drugs And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Landmark Foundation Private LimitedBajranglal Choudhary, Shree Choudhary and 1 more are mutual person
- Shree Shourya Creators Private Limited
Shree Choudhary is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eastern Drugs And Research Centre?
Unlock and access historical data on people associated with Eastern Drugs And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eastern Drugs And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eastern Drugs And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
